1.Application of Microsoft Excel Worksheet to Management of Drugs in Hospital
China Pharmacy 1991;0(01):-
OBJECTIVE: To strengthen drug management in hospital.METHODS: Hospital Information System(HIS)-based drug management was supplemented and consummated with the help of Microsoft Excel worksheet's functions such as ranking,computing and advanced screening etc.RESULTS: Using the Microsoft Excel worksheet to help monitor inventory control,warehousing,and shortage of drug supply,unsalable drugs and expiration date in HIS-based drug management has facilitated the effective management on both the quality and the quantity of drugs in our hospital.CONCLUSIONS: Microsoft Excel worksheet can be utilized to consummate HIS-based electronic management of drugs in hospital.
2.Characterization of proteins in hyperlipidemia pancreas using differential gel electrophoresis and tandem mass spectrometry
Wei ZHANG ; Xingpeng WANG ; Zhuowei YU ; Yue ZHU ; Xiaofeng YU ; Kai WU ; Yue ZENG ; Mingyi XU
Chinese Journal of Pancreatology 2008;8(2):101-104
Objective To investigate the mechanism of hypedipidemia on pancreas of rats by comparative proteomic analysis.Methods Ten male SD rats were randomly divided into two groups,the experimental group Was fed with high lipid forage and the control group Was fed with normal food.Pancreatic samples from the two groups were harvested six weeks later.Differential protein analysis Was performed using differential in-gel electrophoresis(DIGE),and characterizing the protein biomarkers using tandem mass spectrometry.Western blot Was used to confirm the expression of significantly changed proteins.Results Compared to the normal pancreas tissue,a total of 3 protein spot-features were found to be significantly increased and 11 significantly decreased in pancreatic samples with hyperlipidemia.Significantly increased proteins in hyperlipidemia pancreatic samples were arginaseⅡ,ribonuclease inhibitor and glyeine amidinotransferase,which increased by 2.19,1.82 and 1.12 fold,respectively.Significantly decreased proteins in hyperlipidemia group were tyrosyl-tRNA synthetase,alpha-amylase,triacylglycerol lipase,DJ-1protein,Cu,Zn superoxide dismutase,which dicreased by 2.48,2.37,1.85,1.73 and 1.65 folds,respectively.Western blot analysis revealed increased arginase Ⅱ levels and decreased alpha-amylase in pancreatic samples with hyperlipidemia.Conclusions Pancreas wag possibly injured by hyperlipidemia via increase of arginase Ⅱ.Decreased amylase and lipase may be the protection mechanism of pancreas.
3. The role of poloxamer 188 for cord blood mononuclear cells into megakaryocytes cultivation and induction in three-dimensional WAVE Bioreactor
Lin CHEN ; Wen YUE ; Xiaoyan XIE ; Xiuyuan ZHANG ; Yang LYU ; Daqing LIU ; Jiafei XI ; Mingyi QU ; Zeng FAN ; Fang FANG ; Xuantao PEI
Chinese Journal of Hematology 2018;39(1):28-31
Objective:
To observe the effect of poloxamer 188 (P188) on megakaryocyte cultivation and induction from cord blood mononuclear cells in order to obtain more megakaryocyte progenitor cells (MPC).
Methods:
The cord blood mononuclear cells were isolated and inoculated in cell culture bag or cell culture flask respectively. The WIGGENS shaker and cell culture bags were used to mimick WAVE Bioreactor for three-dimensional (3D) cell culture, and the P188 was added to induction medium, The cells were detected for morphology, surface marker, viability, and number on day 14.
Results:
In the two-dimensional (2D) culture, CD41+, CD41+/CD61+, CD61+ megakaryocytic numbers increased significantly after adding P188 (all
4. Mononuclear cells of umbilical cord blood differentiation to granulocyte cell in vitro
Lin CHEN ; Xiaoyan XIE ; Jiqin NIE ; Dongli CHEN ; Anping HUANG ; Fang FANG ; Mingyi QU ; Xue NAN ; Lijuan HE ; Zeng FAN ; Wen YUE ; Xuetao PEI
Chinese Journal of Hematology 2017;38(6):532-536
Objective:
To explore an optimal method for granulocyte cell production from umbilical cord blood mononuclear cells.
Methods:
Erythrocytes were precipitated by hydroxyethyl starch. Mononuclear cells were isolated through Ficoll density gradient centrifugation. Different media, additives and cultivation model were chosen for granulocyte induction. Cell morphology was observed by microscopy, and cell phenotype was detected by flow cytometry. The CD18 expression of granulocytes was tested by immunofluorescence assay, and phagocytosis test was executed as well.
Results:
Compared to fetal bovine serum (FBS) treatment group, cell viability, counts and differentiation rate of granulocytes induced by X-VIVOTM 15 combined with TPO, SCF, G-CSF but without FBS were superior. And X-VIVOTM15 medium was better than SCGM medium at effectiveness and cost. Using two-stage mode of hematopoietic stem cell expansion followed by granulocyte induction with X-VIVOTM15 combining TPO, SCF and G-CSF, cell proliferation was nearly 132 times at day 21. Flow cytometry showed that the differentiation was lagged in 2-stage mode than in direct induction mode, CD15 expression was (69.60± 1.06) %
5.Role of Nrf2/HO-1 signal axis in the mechanisms for oxidative stress-relevant diseases.
Tiantian WANG ; Chunyuan CHEN ; Lei YANG ; Zhihui ZENG ; Maojun ZENG ; Wen JIANG ; Lin LIU ; Mingyi ZHAO
Journal of Central South University(Medical Sciences) 2019;44(1):74-80
In the development of oxidative stress-relevant diseases, reactive oxygen species (ROS) removal obstacle or excess production results in the damage of the body tissues and organs. Recent studies have demonstrated that nuclear factor E2-related factor 2/heme oxygenase-1 (Nrf2/HO-1) axis played a significant role in anti-oxidative stress. The Nrf2/HO-1 axis counteracts oxidative stress injury by its resistance to inflammation, oxidation, mitochondrial damage and calcium influx, apoptosis, pyroptosis, ferroptosis and autophagy, which provides a theoretical basis for its therapeutic effect on various oxidative stress-relevant diseases in multiple organs (respiratory, cardiovascular, nervous, digestive, urinary and blood systems). Therefore, effective regulation of the Nrf2/HO-1 signal axis can be an important strategy for treatment of oxidative stress-relevant diseases.
Heme Oxygenase-1
;
NF-E2-Related Factor 2
;
Oxidative Stress
;
Reactive Oxygen Species
;
Signal Transduction